Advanced Prostate Cancer Consensus Conference (APCCC)

27 April 2022
Translational Prostate Cancer Symposium
Hybrid

28 - 30 April 2022
APCCC
Lugano / Switzerland
Hybrid Conference

APCCC 2022 - Programme Register NOW Translational Prostate Cancer Symposium 27 April 2022 - Programme APCCC 2021 - Recordings APCCC 2019 - report

NOTICE ON APCCC 2021 / 2022

The APC Executive Committee is highly conscientious of the impact that the current COVID-19 pandemic has on travel and event restrictions. We strongly believe in mitigating the spread of the virus while still maintaining the ability to facilitate the exchange between experts, and positively impact the lives of patients with advanced prostate cancer.

Therefore the APCCC 2022 is planned as a hybrid event. We will hold the conference as a face-to-face meeting, while providing the benefits of the conference in an online format. This opens opportunities for attendance to valuable experts from around the world, who may otherwise not be able to attend. Additionally, it provides us the flexibility to move to a completely virtual format, should a face-to-face meeting not be feasible.

Stay Connected

Find below our Twitter-Feed to get the hottest news.
APCCC22

RT @DrYukselUrun: 🔸H3K9 trimethylation machinery is linked to poor outcomes in men with #prostatecancer 🔸Blockade of this epigenetic axis c…

APCCC_Lugano 27 May
APCCC22

RT @NehaVapiwala: Such fun to catch up with old - and new - friends @APCCC_Lugano, both on & off camera! No one knows how to work the mike…

APCCC_Lugano 26 May
APCCC22

RT @WCMEnglanderIPM: ICYMI: @WCMEnglanderIPM Clinical Director Dr. Cora Sternberg (@cnsternberg) co-authoered "Management of Patients with…

APCCC_Lugano 26 May
APCCC22

RT @ProfJOSullivan: How to follow our #lugano #apccc22 gig? Easy! The Belfast City Hospital Sping Arts Festival at the Cancer Centre tonigh…

APCCC_Lugano 26 May
APCCC22

RT @urotoday: Radium-223 + enzalutamide vs enzalutamide in patients with progressive metastatic castration-resistant #ProstateCancer. @neer…

APCCC_Lugano 26 May
APCCC22

RT @Silke_Gillessen: 5-year follow-up results from STAMPEDE for Abiraterone acetate plus prednisolone for metastatic Prostate cancer https:…

APCCC_Lugano 26 May